Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 6.4% Above Its 50 Day AverageFinance DailyCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella a… Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded Over Its 50 Day Moving AverageFirst News 24CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella … Continue reading
Editas Medicine, Inc. (NASDAQ:EDIT) Stock Closed 6.4% Above Its 50 Day AverageFinance DailyCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella a… Continue reading
Technology NetworksNew Approach Could Offer a Better Way to Make Stem CellsTechnology NetworksIn a study published in an Advance Online paper in Nature Biotechnology, the TSRI scientists screened a library of 100 million antibodies and found several th… Continue reading
Technology NetworksNew Approach Could Offer a Better Way to Make Stem CellsTechnology NetworksIn a study published in an Advance Online paper in Nature Biotechnology, the TSRI scientists screened a library of 100 million antibodies and found several th… Continue reading
|
Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In …
Clinical Leader Plymouth Meeting, PA (GLOBE NEWSWIRE) – Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced that an interim data analysis showed that its INO-5150 cancer immunotherapy product generated antigen-specific CD8+ killer T cell responses … |
|
CRISPR breakthrough ignites hope of using pigs as organ donors
ScienceNordic It is the second problem that scientists have now solved with the gene-editing tool, CRISPR. “We’ve switched off the porcine endogenous retroviruses (PERVs) in the pigs, so that the PERVs can no longer replicate itself and infect people,” says Luo. |
|
CRISPR breakthrough ignites hope of using pigs as organ donors
ScienceNordic It is the second problem that scientists have now solved with the gene-editing tool, CRISPR. “We’ve switched off the porcine endogenous retroviruses (PERVs) in the pigs, so that the PERVs can no longer replicate itself and infect people,” says Luo. |